liberDi Receives FDA Regulatory Clearance for its Digital Dialysis System
Misgav, Israel, XX January 2023 – liberDi Ltd., a portfolio company of The Trendlines Group Ltd. (“Trendlines”) (SGX: 42T; OTCQX: TRNLY), announced today that it has received regulatory clearance from the United States Food and Drug Administration (FDA) for its Digital Dialysis Clinic, which allows patients to perform dialysis at home or at the workplace,…